Keyphrases
Virus Infection
100%
Mouse Model
100%
Rift Valley Fever Virus
100%
Virus Diseases
100%
Tilorone
100%
Rift Valley Fever
22%
RNA Virus
11%
Mosquito-borne
11%
MP-12
11%
Further Development
11%
Antiviral Activity
11%
Balb C Mice
11%
Mandatory Vaccines
11%
Zoonotic Disease
11%
Lethal Dose
11%
Africa
11%
Micromolar Concentration
11%
Improved Survival
11%
Respiratory Infection
11%
Antiviral Therapeutics
11%
DNA Virus
11%
Pre-exposure Prophylaxis (PrEP)
11%
Middle East
11%
Antiviral Efficacy
11%
Broad-spectrum Antivirals
11%
Survival Outcomes
11%
Ruminant Livestock
11%
Eastern European Countries
11%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Virus Infection
100%
Rift Valley Fever Virus
100%
Tilorone
100%
Antivirus Agent
33%
Infection
22%
Rift Valley Fever
22%
Disease
11%
Antiviral Activity
11%
Bagg Albino Mouse
11%
Virus RNA
11%
Respiratory Tract Infection
11%
Zoonosis
11%
Virus DNA
11%
Immunology and Microbiology
Viral Disease
100%
Mouse Model
100%
Rift Valley Fever Virus
100%
Tilorone
100%
Rift Valley Fever
22%
RNA Virus
11%
Antiviral Activity
11%
Bagg Albino Mouse
11%
Zoonosis
11%
DNA Virus
11%
Medicine and Dentistry
Virus Infection
100%
Rift Valley Fever Virus
100%
Tilorone
100%
In Vitro
22%
Infection
22%
Antivirus Agent
22%
Rift Valley Fever
22%
Disease
11%
Zoonosis
11%
Virus RNA
11%
Respiratory Tract Infection
11%
Virus DNA
11%
Antiviral Therapeutics
11%
Antiviral Activity
11%
Post-Exposure Prophylaxis
11%